Jeffrey Zhong, MD

Jeffrey Zhong, MD

University Hospitals Cleveland

Latest Content

PARP inhibitor combination therapy in metastatic prostate cancer, featuring Jeffrey Zhong, MD, and Karan Jatwani, MD, with a cityscape background.

Prostate Cancer

03/11/2026

PARP Inhibitor Combination Therapy in Metastatic Prostate Cancer

Karan Jatwani, MDJeffrey Zhong, MD